Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Medtronic; Edwards Lifesciences; Supira; CorFlow; PiCardia